Merck & Co Inc (NYSE: MRK) kicked off on Monday, up 5.87% from the previous trading day, before settling in for the closing price of $75.97. Over the past 52 weeks, MRK has traded in a range of $75.82-$134.63.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 7.14% over the last five years. While this was happening, its average annual earnings per share was recorded 16.55%. With a float of $2.51 billion, this company’s outstanding shares have now reached $2.52 billion.
The firm has a total of 75000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 80.96%, operating margin of 35.78%, and the pretax margin is 31.55%.
Merck & Co Inc (MRK) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Merck & Co Inc is 0.10%, while institutional ownership is 81.18%. The most recent insider transaction that took place on Apr 25 ’25, was worth 352,723. In this transaction SVP Fin. – Global Controller of this company sold 4,262 shares at a rate of $82.76, taking the stock ownership to the 7,778 shares. Before that another transaction happened on Apr 25 ’25, when Company’s Officer proposed sale 4,262 for $82.76, making the entire transaction worth $352,723.
Merck & Co Inc (MRK) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.45 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.07% during the next five years compared to 12.04% growth over the previous five years of trading.
Merck & Co Inc (NYSE: MRK) Trading Performance Indicators
Take a look at Merck & Co Inc’s (MRK) current performance indicators. Last quarter, stock had a quick ratio of 1.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.17. Likewise, its price to free cash flow for the trailing twelve months is 11.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.87, a number that is poised to hit 2.06 in the next quarter and is forecasted to reach 9.78 in one year’s time.
Technical Analysis of Merck & Co Inc (MRK)
Analysing the last 5-days average volume posted by the [Merck & Co Inc, MRK], we can find that recorded value of 16.33 million was better than the volume posted last year of 16.25 million. As of the previous 9 days, the stock’s Stochastic %D was 18.55%. Additionally, its Average True Range was 2.80.
During the past 100 days, Merck & Co Inc’s (MRK) raw stochastic average was set at 16.98%, which indicates a significant decrease from 46.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.52% in the past 14 days, which was higher than the 32.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $85.83, while its 200-day Moving Average is $100.00. Now, the first resistance to watch is $82.52. This is followed by the second major resistance level at $84.62. The third major resistance level sits at $87.96. If the price goes on to break the first support level at $77.08, it is likely to go to the next support level at $73.74. Should the price break the second support level, the third support level stands at $71.64.
Merck & Co Inc (NYSE: MRK) Key Stats
The company with the Market Capitalisation of 201.96 billion has total of 2,511,031K Shares Outstanding. Its annual sales at the moment are 64,168 M in contrast with the sum of 17,117 M annual income. Company’s last quarter sales were recorded 15,529 M and last quarter income was 5,079 M.
